AugustoEVillegasMD

Breast Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Dr. Villegas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4689 US Highway 17 Ste 25
Fleming Island, FL 32003
Phone+1 904-269-6526

Fax+1 904-269-6527

University of Florida College of Medicine JacksonvilleFellowship, Hematology and Medical Oncology, 2003 - 2005
Damas HospitalResidency, Internal Medicine, 1996 - 1999
Ponce Health Sciences University School of MedicineClass of 1996

PubMed

Response of FGFR-2 Positive Adenoid Cystic Carcinoma to Futibatinib: A Case Report.
Yoan E Rodriguez, Maham Shahid, Natalia Badillo, Augusto Villegas, Nilmarie Guzman
Cureus. 2024-06-01
2 citations
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
Johan F Vansteenkiste, Jarushka Naidoo, Corinne Faivre-Finn, Mustafa Özgüroğlu, Augusto Villegas
JTO Clinical and Research Reports. 2024-03-01
2 citations
Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy.
Jay Patel, Augusto Villegas
Cureus. 2023-08-01

Journal Articles

Overall Survival with Durvalumab After Chemoradiotherapy in Stage III NSCLC
David R Spigel, Davey Daniel, Jhanelle E Gray, Augusto Villegas, Tarek Mekhail, Alberto Chiappori, The New England Journal of Medicine
Trastuzumab Emtansine (T-dM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety and Biomarkers
Augusto Villegas, Christina S Baik, Clinical Cancer Research